先鋒新材(300163.SZ):兩子公司擬0元合計受讓北京生利100%份額
格隆匯 3 月 19日丨先鋒新材(300163.SZ)公佈,為進一步提升競爭力,根據公司的整體戰略規劃及經營需求,公司全資子公司北京先鋒通達電子商務科技有限公司(“先鋒通達”)、武威先鋒物流貿易有限公司(“武威先鋒”)於2021年3月19日同華原基金管理(北京)有限公司(“華原基金”)、江蘇中利控股集團有限公司(“江蘇中利”)簽訂合夥份額轉讓協議,擬以0元對價分別受讓華原基金和江蘇中利所持有的北京生利投資管理中心(有限合夥)(“北京生利”)20%和80%份額。截至目前,北京生利註冊資本1000萬元。
公司此次對外投資主要為滿足公司的戰略發展需要,有助於擴大公司業務規模、拓展業務領域、增加公司營業收入及淨利潤,提升公司的綜合競爭力,符合公司長遠發展規劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.